Iconix Signs Licensing, Research Deals with BMS, Abbott

genomeweb
360dx

Iconix Signs Licensing, Research Deals with BMS, Abbott

Jan 21, 2004

NEW YORK, Jan. 21 (GenomeWeb News) - Iconix Pharmaceuticals has signed research and technology licensing deals with Bristol-Myers Squibb and Abbott Laboratories, the company said today.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

People in the News: Hilde Furberg, Caroline Loew, Stanley Lapidus, More
In Brief This Week: Precipio, LunaDNA, NRGene, and More
Amended Lawsuit Against Illumina, Thermo Fisher, Others Names Additional Defendants
Genealogy Data Helps Track Back Rare Disease Alleles to Quebec Founder Families
Enpicom, Glycostem Therapeutics Receive Immunotherapy Research Grant
Illumina Donates Genotyping Arrays to All of Us Research Program

The Scan

Hackers Go After Genome Data

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

What's This Personalized Medicine?

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

No Gene Drive Ban

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

This Week in Science

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.

Main menu